News
-
The Lundquist Institute and Its Start-Up Company Vitalex Biosciences Announce Strategic Advancement of Second-Generation Fungal Vaccine VXV-01 Through Phase 1 Trials Under $40 Million Competitive Contract From NIH/NIAID
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal vaccine candidate known as VXV01, which was…
ResearchNovember 12, 2025 -
From Battlefield to Bench: Jeff Chen’s Mission to Heal
When asked about his childhood, Jeff Chen will tell you he “wasn’t the brightest kid,” but what he really means is that he hadn’t found his…
CommunityNovember 11, 2025 -
The Heart of WIC: Marisela Montoya Turns Experience into Empowerment
When Marisela Montoya, EdD walks through the doors of the South Los Angeles Health Projects office each morning, she often takes a quiet moment to reflect.…
CommunityNovember 6, 2025 -
Honoring Discovery and Dedication: Legends 2025 Celebrates Innovation at The Lundquist Institute
The Lundquist Institute’s annual Legends celebration brought together a full house of faculty, partners, and friends for an inspiring evening dedicated to the power of science, collaboration, and…
Leadership, ResearchNovember 4, 2025 -
The Lundquist Institute Awarded $9 Million to Launch Community Center of Excellence for Regenerative Medicine
Christina Wang, MD, and Lynda Polgreen, MD, MS, investigators at The Lundquist Institute for Biomedical Innovation, have been awarded $9 million from the California Institute for Regenerative Medicine (CIRM) to…
CommunityOctober 30, 2025 -
The Lundquist Institute’s Dr. Dong Chang Receives $3.16 Million NIH Grant to Improve ICU Care and Shared Decision-Making
The Lundquist Institute is proud to announce that Dong Chang, MD, MS has been awarded a prestigious R01 grant from the National Institutes of Health (NIH)/National Institute on Aging,…
ResearchOctober 27, 2025 -
Dr. Loren Miller presents oral late breaker at IDWeek 2025 of a first-of-its-kind clinical trial that shows efficacy of bacteriophage therapy for Staphylococcus aureus bacteremia
During IDWeek 2025 in Atlanta, Georgia, Loren G. Miller, MD, MPH, investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, presented landmark findings from the Phase 2a diSArm study.…
ResearchOctober 27, 2025 -
The Lundquist Institute Team Discovers Possible Biomarker for Long COVID
Investigating the Roots of Long COVID Investigators from The Lundquist Institute, Asghar Abbasi, PhD, and William Stringer, MD, sought to understand whether viral persistence acts as…
ResearchOctober 24, 2025 -
Bridging Research and Care: Dr. Christine Dauphine on Breast Cancer Risk and Prevention
October marks Breast Cancer Awareness Month — a time to educate, empower, and encourage proactive screening. To help shed light on prevention, early detection, and ongoing…
ResearchOctober 23, 2025 -
From Rural India to Prestigious Medical Institute: How Dr. Rajesh Garg Instills Meaning in Medicine
When Rajesh Garg, MD talks about his life, he doesn’t sound like the kind of doctor who grew up knowing he wanted to wear a white coat. His…
Community, ResearchOctober 22, 2025